Lung Cancer Trial, Recruiting NCT06122064 Sponsor: Mayo Clinic Condition: Lung Cancer
Back to Lung Cancer

Lung Cancer Trial, Recruiting

NCT06122064
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

For clinicians:

  • Doctors, fellows, residents, physician assistants, or nurse practitioners working in the departments taking part in the study are eligible to join

For patients:

  • You must be 18 years of age or older
  • You must have appointments at Mayo Clinic in Rochester
  • You must have been diagnosed with non-small cell lung cancer (a common type of lung cancer) at a stage higher than 1B (meaning it has progressed beyond an early stage)
  • Your cancer specialist (oncologist) must consider you eligible for additional treatment after your main treatment (such as after surgery)

Who may not be able to join:

  • Patients who have significant difficulties giving written consent or taking part in discussions about their care — for example, due to dementia or severe hearing or vision problems — may not be able to participate

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 30 June 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Registry
ClinicalTrials.gov
Start date
20 November 2023
Est. completion
31 October 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Effectiveness of the intervention on implementing shared decision making; Degree of involvement of patients by the clinician in the shared decision making; Provider satisfaction with NSCLC choice conversation aid

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 30 June 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov